Assessment ofin silicomodels for fraction of unbound drug in human liver microsomes
- 18 February 2010
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Metabolism & Toxicology
- Vol. 6 (5), 533-542
- https://doi.org/10.1517/17425251003671022
Abstract
Importance of the field: Fraction of unbound drug in human liver microsome (fumic) incubation media is an important parameter for accurate assessment of hepatic intrinsic clearance and drug–drug interactions. In recent years, there have been considerable advances in understanding structure–microsomal binding relationships. Areas covered in the review: This review highlights the in silico modeling techniques for fumic including physicochemical properties-based modeling, pharmacophore feature-based classification modeling and more complex statistical method-based modeling. The application of these modeling techniques to the understanding of the structure-binding relationships is also discussed. What the reader will gain: The reader will gain an understanding of the modeling techniques used for prediction of binding to human liver microsomes (fumic). The reader will also understand the molecular structure–microsomal protein binding relationships. In all of these models, lipophilicity is the most important molecular property underlying the structure-binding relationship. Other molecular properties such as charge type (positive vs negative) and hydrogen bonding are also important factors for microsomal binding. Take home message: The predictive accuracy of fumic models in the high lipophilicity and tight microsomal binding ranges still needs to be further improved. However, in silico models are still valuable tools to aid chemical library design and prioritize multiple chemical series, which could provide efficiency and decrease knowledge cycle times in drug discovery.Keywords
This publication has 46 references indexed in Scilit:
- In Silico Modeling of Nonspecific Binding to Human Liver MicrosomesDrug Metabolism and Disposition, 2008
- The Impact of In Vitro Binding on In Vitro - In Vivo Extrapolations, Projections of Metabolic Clearance and Clinical Drug-Drug InteractionsCurrent Drug Metabolism, 2006
- THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2003
- Impact of Nonspecific Binding to Microsomes and Phospholipid on the Inhibition of Cytochrome P4502D6: Implications for Relating in Vitro Inhibition Data to in Vivo Drug InteractionsDrug Metabolism and Disposition, 2003
- The Role of Absorption, Distribution, Metabolism, Excretion and Toxicity in Drug DiscoveryCurrent Topics in Medicinal Chemistry, 2003
- Microsomal Protein Concentration Modifies the Apparent Inhibitory Potency of CYP3A InhibitorsDrug Metabolism and Disposition, 2002
- Prediction of ‘drug-likeness’Advanced Drug Delivery Reviews, 2002
- Drug-like properties and the causes of poor solubility and poor permeabilityJournal of Pharmacological and Toxicological Methods, 2000
- Computational methods for the prediction of ‘drug-likeness’Drug Discovery Today, 2000
- Blood Levels of Drug at the Equilibrium State after Multiple DosingNature, 1965